Global Owren's Disorder Market Growth 2025-2031
Description
The global Owren's Disorder market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Owren’s disease is also termed as Factor V or parahemophilia. It is a type of rare bleeding disorder that results in poor clotting after an injury or surgery. Factor V deficiency should not be mixed with factor V Leiden mutation, which is a much more common condition that leads to severe blood clotting.
United States market for Owren's Disorder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Owren's Disorder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Owren's Disorder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Owren's Disorder players cover Pfizer Inc, Merck KGaA, Sanofi, Biocare Medical, LLC, Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Owren's Disorder Industry Forecast” looks at past sales and reviews total world Owren's Disorder sales in 2024, providing a comprehensive analysis by region and market sector of projected Owren's Disorder sales for 2025 through 2031. With Owren's Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Owren's Disorder industry.
This Insight Report provides a comprehensive analysis of the global Owren's Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Owren's Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Owren's Disorder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Owren's Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Owren's Disorder.
This report presents a comprehensive overview, market shares, and growth opportunities of Owren's Disorder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Prothrombin Complex
Desamino-D-Arginine Vasopressin
Adrenocorticotropic Hormone
Antifibrinolytics
Other
Segmentation by Application:
Hospitals
Specialty Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer Inc
Merck KGaA
Sanofi
Biocare Medical, LLC
Lilly
Teva Pharmaceutical Industries
Mitsubishi Chemical Group Corporation
Bristol-Myers Squibb Company
GSK plc
Bayer AG
AstraZeneca
Zimmer Biomet
DAIICHI SANKYO COMPANY, LIMITED
Crystal Genomics Inc
ABIOGEN PHARMA S.p.A
Key Questions Addressed in this Report
What is the 10-year outlook for the global Owren's Disorder market?
What factors are driving Owren's Disorder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Owren's Disorder market opportunities vary by end market size?
How does Owren's Disorder break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Owren’s disease is also termed as Factor V or parahemophilia. It is a type of rare bleeding disorder that results in poor clotting after an injury or surgery. Factor V deficiency should not be mixed with factor V Leiden mutation, which is a much more common condition that leads to severe blood clotting.
United States market for Owren's Disorder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Owren's Disorder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Owren's Disorder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Owren's Disorder players cover Pfizer Inc, Merck KGaA, Sanofi, Biocare Medical, LLC, Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Owren's Disorder Industry Forecast” looks at past sales and reviews total world Owren's Disorder sales in 2024, providing a comprehensive analysis by region and market sector of projected Owren's Disorder sales for 2025 through 2031. With Owren's Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Owren's Disorder industry.
This Insight Report provides a comprehensive analysis of the global Owren's Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Owren's Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Owren's Disorder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Owren's Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Owren's Disorder.
This report presents a comprehensive overview, market shares, and growth opportunities of Owren's Disorder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Prothrombin Complex
Desamino-D-Arginine Vasopressin
Adrenocorticotropic Hormone
Antifibrinolytics
Other
Segmentation by Application:
Hospitals
Specialty Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer Inc
Merck KGaA
Sanofi
Biocare Medical, LLC
Lilly
Teva Pharmaceutical Industries
Mitsubishi Chemical Group Corporation
Bristol-Myers Squibb Company
GSK plc
Bayer AG
AstraZeneca
Zimmer Biomet
DAIICHI SANKYO COMPANY, LIMITED
Crystal Genomics Inc
ABIOGEN PHARMA S.p.A
Key Questions Addressed in this Report
What is the 10-year outlook for the global Owren's Disorder market?
What factors are driving Owren's Disorder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Owren's Disorder market opportunities vary by end market size?
How does Owren's Disorder break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
117 Pages
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Owren's Disorder by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Owren's Disorder by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
